HELP Cybin Inc.
Company Analysis
Latest News
🟢 Cybin is trading 5.7% up today as biotech sector gains
Cybin is trading at $11.57, up +5.72%, with the move best explained by biotech-sector strength. - Biotech ETF XBI is up 2.10%, while sector sentiment is...
🟢 Cybin is trading 5% up today amid broader biotech gains
Cybin is trading at $11.25, up 5.24%; broader biotech strength is the likeliest available context, not a confirmed cause. - No clear company-specific...
🟢 Cybin is trading 5.5% up in pre-market with no clear company-specific catalyst identified
Cybin is trading at $11.13, up +5.50%, with no clear company-specific announcement identified to explain the pre-market rise. - A Wall Street Zen rating...
🔴 Cybin is trading 5.4% down today amid broader biotech and risk-sensitive stock pressure
Cybin is trading 5.4% lower at $10.45 on October 16, 2026, amid pressure on biotech and other risk-sensitive stocks. - XBI is down 2.06%, while major U.S....
🟢 Cybin is trading 5% up today
Cybin is trading 5.2% up at $10.92, though available coverage does not directly link the move to a specific catalyst. - On October 15, the company announced it...
🔴 Cybin is trading 5.9% down today with no company-specific catalyst identified
Cybin is trading 5.9% down at $10.38, with no company-specific announcement or reliable report identified for October 13, 2026, to explain the decline. - The...
🟢 Cybin is trading 8.6% up in pre-market with no clear catalyst identified
Cybin is trading at $11.98, up +8.63%, with the cause of the October 13 pre-market rise unclear. - No fresh company announcement or reliable report was...
🔴 Cybin is trading 5% down on October 12, 2026 — no clear catalyst identified
Cybin is trading at $11.20, down 5.08% during the October 12 session, with no clear company-specific or broad-market catalyst identified. - No October 12...
🟢 Cybin is trading 11% up with no clear company-specific catalyst
Cybin is trading 10.68% up at $11.87 on October 9, 2026, with no clear company-specific announcement explaining the move. - The latest company news is an...
🟢 Cybin is trading 5% up
Cybin is trading up 5.32% at $11.29 on October 9, 2026, with no reported company-specific announcement clearly explaining the intraday gain. - The latest...
🔴 Cybin is trading 6.6% down today amid biotech-sector weakness
Cybin is trading 6.6% down at $10.67, with biotech-sector weakness potentially weighing on shares. - No clear company-specific catalyst for October 6 has...
🟢 Cybin is trading 7% up in pre-market
Cybin is trading 7.07% higher in pre-market at $13.48, versus its September 28 close of $12.59; no confirmed company-specific catalyst was identified. -...
🟢 Cybin is trading 5.19% up in pre-market after HLP003 12-month efficacy data
Cybin is trading 5.19% higher at $13.24 after 12-month HLP003 efficacy data in major depressive disorder were presented at Psychiatry Congress 2026. - The...
🔴 Cybin is trading 5.38% down today as biotech stocks fall with broader markets
Cybin is trading 5.38% lower at $12.32 as broader market weakness pressured biotechnology and growth stocks. - The Nasdaq Composite is down 0.73%, while...
🔴 Cybin is trading 5.4% down today amid broader risk-off conditions
Cybin is trading at $12.97 (-5.39%) amid broader risk-off conditions. - On September 23, 2026, the Nasdaq was down 0.94% and the S&P 500 was down 0.55%. - No...
🟢 Cybin is trading 5% up in pre-market after four HLP003 presentations at Psych Congress 2026
Cybin is trading at $14.37, up 5.21% after releasing four HLP003 research presentations at Psych Congress 2026. - Analyses included 12-month efficacy findings...
Helus Pharma Pops 11% on Depression Drug Data Blitz, but Can It Keep Up in a Crowding Psychedelic Race?
Shares shifted sharply higher Monday as Helus Pharma (ticker: HELP), the company formerly known as Cybin, unveiled four research presentations at Psych...
🟢 Cybin is trading 10.75% up today after four HLP003 presentations at Psych Congress 2026
Cybin is trading 10.75% up at $13.70 after announcing four HLP003 poster presentations at Psych Congress 2026. - Presentations include updates from its Phase...
🟢 Cybin is trading 5.94% up today as major U.S. indexes gained more than 0.5%
Cybin is trading 5.94% up now at $13.11 after opening on September 21, 2026, likely reflecting a broader risk-on backdrop as major U.S. indexes gained more...
🔴 Cybin is trading 10.7% down today
Cybin is trading at $12.52 (-10.70%) with no confirmed company-specific catalyst identified for September 18, 2026. - The September 16 Morgan Stanley...